Clinical trial
A Multicenter, Randomized Trial of Preterm Infants Receiving Caffeine and Less Invasive Surfactant Administration Compared to Caffeine and Early Continuous Positive Airway Pressure (CaLI Trial)
NCT04209946 is registered in ClinicalTrials.gov with Sharp HealthCare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized Trial of Preterm Infants Receiving Caffeine and Less Invasive Surfactant Administration Compared to Caffeine and Early Continuous Positive Airway Pressure (CaLI Trial)
- Lead sponsor
- Sharp HealthCare
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 22, 2020
- Completion date
- November 10, 2025
- Enrollment
- 180 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
premature lungs, respiratory distress syndrome, surfactant deficiency syndrome neonatal